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Apoptotic Neurodegeneration in the Developing Human Brain:
Possible Role of General Anesthetics in its Genesis, and of
L-Carnitine in its Reversal
Yisroel Yitzchok Rosenfeld
Abstract
Recent studies suggest that general anesthetic (GA) agents administered to developing rats, through its mechanism as
an NMDA antagonist or a GABAa mimetic, may damage developing neural cells by inducing a higher rate of programmed
cell death (apoptosis). Similar heightened degeneration was also apparent in higher primates such as the monkey. This
warrants strong concern, as every year thousands of pregnant women and children below 1 year of age undergo a surgical procedure in which GAs are used. A spike in neuroapoptosis may lead to long term cognitive deficiencies lingering
into adulthood. Are humans vulnerable to these affects? Different pathways are under investigation as to the cause of
the damage in animals, but humans have different metabolic pathways than even higher primates, and the basic mechanism by which GAs take affect is not well understood. Scientists continue to unravel the underlying mechanism, seeking
to stop the apoptotic cascade, all the while maintaining the benefits of the sedative effect. Promising new hope comes
transmission between the spinal cord and the brain (Olney
et al. 1991). NMDA receptors are important in the function
of neuronal migration and differentiation, synaptic plasticity, and in promoting learning and memory. Glutamate receptors are the most common excitatory neurotransmitter
found in mammals. NMDA glutamate receptor antagonists
include ketamine and nitrous oxide, both widely used in
pediatric anesthesia. The collective effect of GABAa agonists and NMDA antagonists is to block synaptic transmissions from occurring between neurons and the spinal cord.

Introduction
Anesthetic Pathway / Mechanism

For conformation to occur between an anesthetic
agent and its target, it would be expected that the agent
would be highly specific. But the broad arrays of such
agents, with their varied structural and chemical compositions seem to belie such a nature. Nevertheless, all general
anesthetics work through either of two primary transmission mechanisms: NMDA (N-methyl-D-aspartate) receptor
antagonists or GABA mimetic receptors (gammaMethods
aminobutyric acid).
Data presented in this paper was mined from case
GABA receptors, a type of ligand-gated ion chanstudies, review articles, online sources, and scientific journel, are the main inhibitory neurotransmitter in the central
nals using search engines of the Touro College Library danervous system (Colquhoun et al. 2004). The sedative
tabase, EBSCO, Pubmed, and Google Scholar.
effect of the GABAa agonists is caused by the inhibition of
firing new action potentials. When molecules bind extra- Discussion
cellularly, a selective Cl ion pore is opened. This increased
Effects on lower mammals
accessibility of the Cl ion drives it towards -65mV, a membrane potential at which there is no overall change in the Deleterious effects of anesthetics on developing neural
ion concentration on either side of the membrane, a situa- cells was first observed in extensive exposure of rat pups
on postnatal days 0,3,7, and 21 to Dizocilpine [(+)MK 801],
tion called reversal potential.
an NMDA receptor antagonist (Ikonomidou et al. 1999).
NMDA receptor antagonists block the glutamate
NMDA receptor activation promotes survival of their reand glycine from binding to the receptor, blocking signal
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spective cells. Even brief periods of inhibition were shown
to cause brain-wide apoptosis. Rats were injected variously
with .5mg, .75, and 1mg per kg of body weight and apoptosis was measured after 24 hours using terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL).
TUNEL is a common technique for identifying DNA fragmentation representative of apoptotic signaling cascades
by marking the terminal end of nucleic acids.

Embryonic rats in utero were also given 0.5mg (+)MK 801
at embryonic days 17, 19, and 21 for 8 or 16 hours, and
were examined after 24 hours. Significant apoptosis occurred in the embryonic 21 day old rats in the dentate gyrus, hippocampus and hypothalamus. Embryonic day 19
rats showed some modest apoptosis while embryonic day
17 rats showed no sign of apoptosis.
At certain points in the postnatal period rats were
more vulnerable to neural degeneration than during the
fetal period. Increased vulnerability in the postnatal period
may result from the subunit composition of the NMDA receptor which is modified in the transition from the embryonic to the postnatal stage. Higher expression of NMDA
receptors at certain periods would make the cells more
vulnerable to the NMDA antagonist.

Pervasive apoptosis was perceived throughout the
brain including within the hippocampus, dentate gyrus,
thalamus, hypothalamus, frontal cortex, parietal cortex,
cingulate cortex, and retrosplenial cortex, as evidenced by
decreased cell density. The apoptotic effect was most pronounced in 7 day old rats when expression of NMDA receptors peak. The neural deletion was commensurate with
the influence of both dosage and time factors (Figure 1A).
The enantiomer, (-)MK 801, known to be less effective in
its ability to inhibit NMDA receptor signal transmission,
was also tested. The effects of (-)MK 801 remained negligible relative to the vehicle treated rats (the control; rats just
given the solvent without the active ingredient, MK801) up
to a dose of 1.0 mg/kg. Electron microscopy demonstrated
that these degenerate cells showed no physiological or
ultrastructural distinction from corresponding apoptotic
cells.

Most concerning was that ketamine, a common
pediatric anesthetic, was also shown to cause neuroapoptosis in the developing rat brain. Humans are more developmentally advanced than rats and these results are difficult to extrapolate, but these findings suggest a period of
susceptibility in humans during the corresponding period.
This time frame is controversial, and an early postnatal
study in rats may compare to late gestation or the newborn stage. Perhaps the danger exists throughout the corresponding brain growth spurt period (synaptogenesis)
which lasts from mid-gestation to several years after birth.

Figure 1: Part (A) shows the detrimental effect of MK 801 is proportional to the dosage. Solid circles denote (+)MK 801; Empty
circles represent (-)MK 801. The dashed line represents vehicle
treated rats. Part (B) demonstrates a relationship between the
degeneration and the time of exposure. Only (+)MK 801 was
used. The dashed line shows the level of spontaneous apoptosis. (Source: Ikonomidou et al.1999)

GAs were also shown to have a time dependent
effect with apoptosis shown to continually accentuate
when rats were given 0.5mg/kg and were killed variously at
4,8,12,16,24, and 48 hours after being subjected. With the
passage of just 4 hours apoptotic effects were apparent. A
peak effect was reached after 24 hours while after 48
hours the effects mostly subsided (Figure 1B).

Apoptosis - Essential for Life
During normal development of the central nervous system apoptosis plays an integral part in the development. Signals that proliferate or restrain the apoptotic
program using a precise biochemically guided system
controls the number of cells extant and are important in
shaping controlling and establishing the development of
cells. When apoptotic caspases were eliminated to block
the apoptotic mechanism in rats, abnormalities such as
66

Genesis and Reversal of Apoptotic Nuerodegeneration in Developing Brain

increased subpopulations in the brain occurred and in
some cases resulted in lethality. Apoptosis further aids in
sexual differentiation, development of olfactory and thermoregulatory systems, and processing of pheromones
(Broad et al. 2009). While a moderate amount of neural
cells undergo apoptosis to support healthy development,
the number of cells undergoing apoptosis in regions
throughout the brain upon administration of general anesthetics was excessive.

paired in the anesthetic cocktail rats by use of a radial arm
maze, with a significant learning deficit as compared to the
performance of the control.
Ikonomidou et al. (1999) learned that NMDA
receptor antagonists can cause apoptosis. Wang et al.
(2012) however contends that rats subjected to a dosage
commonly used in clinical settings [NMDA receptor antagonist N2O (70%), or to the GABAa agonists ISO (1%)] showed
no significant measure of apoptosis upon harvest and
TUNEL examination after 6 hours. Rather, they needed to
be subjected to prolonged and substantial doses of the
NMDA receptor antagonist N20 or ISO for any measurable
damage (Figure 2).

Do disturbances in other major excitatory transmitter systems of the brain also cause widespread
neuroapoptosis? No, it is not apparent in antagonists of
excitatory pathways such as the muscarinic or non-NMDA
glutamate antagonists. Nor does it occur in agonists of the
inhibitory dopaminergic system. Only with the use of
NMDA antagonists and GABAa agonists is widespread
apoptosis apparent (Ikonomidou et al. 1999). Because of
these discoveries, researchers set out to discover the
effects of GABAa mimetics, NMDA antagonists, and the
combined neurotoxic effects of the two.

Separate administration did not cause significant
apoptosis, but when administered concurrently, apoptotic
levels were accentuated. While gene expression was
altered when N2O and ISO was delivered independently
the pathways of these genes are not closely associated
with neurons, suggesting that cascades are inducing apoptosis rather than the anesthetic doing so directly. This provides hope to researchers. If the anesthetic itself does not
directly cause the damage but instead generates a cascade
to do so, scientists may be able to determine the point at
which the damage occurs. A drug can then be developed
to act in concert with the anesthetic and inhibit propagation of the damaging pathway. Accordingly, pediatric surgeons can continue to benefit from the sedative effects
without concern for the health of the developing brain.

Permanent Effects on Intelligence

Even presuming robust apoptotic effects upon subjection to anesthetics, what practical significance would it
have? Jevtovic-Todorovic et al. (2003) showed that
exposure of developing rodents to anesthetics results in a
decline in brain density leading to a long-term decline in
cognitive function. Seven day old rats were anesthetized
for 6 hours with N2O, isoflurane (ISO), and midazolam
(triple anesthetic cocktail). They were put in the Morris
Water maze and trained to swim to an observable stand. Figure 2. The apoptotic damage in the ISO + N2O group relative
Their performance concerning path length and vigor in the to the control is apparent (Source: Wang et al. 2012)
Morris Water maze was on a par with that of the
control. When the stand was submerged in the
same location, the triple anesthetic cocktail rats
showed substantial learning deficits in the middle
trials, although they performed at the same level as
the controls by the test’s conclusion. When retested
as adults, their lower memory capacity was evident
when they spent less time searching for the
submerged stands in the area of the pool in which it
was had formerly been raised. Control rats spent
more time searching the appropriate pool area for the
stand’s location. Spatial memory was shown to be im67
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impervious to their affects. Zou et al. (2009) demonstrated
this was not so. However, in contrast with the earlier rat
studies, the primate monkeys needed to be overwhelmed
by a high dosage of ketamine (20 mg/kg) for degeneration
to occur. An initial intramuscular injection of 20 mg/kg was
followed by continuous intravenous administration of
20-50 mg/kg h for 3, 9, or 24 hours. The monkeys were
dispatched after a 6 hour period to allow the anesthetics to
take effect. Ketamine was confirmed with liquid
chromatography and mass spectrometry. Brain slices of 40
micrometers were prepared using a microtome and a
polyclonal antibody that detects cleaved caspase-3, an
effector of apoptosis. Out of all sections of the brain- the
hippocampus, amygdala, cerebellum, cerebrum, thalamus,
and striatum, apoptosis was concentrated mainly in the
frontal cortex.

Widespread Effects Observed
How serious are the effects generated by
neuroapotosis? Huang et al. (2012) proposed that ketamine causes permanent learning and memory impairment.
Postnatal day 7 rats were given doses of 25, 50, and 75
mg/kg of ketamine for 3 days. At two months old, the
group subjected to 75 mg/kg had a diminished capacity for
memory and learning, as measured by the Morris water
maze. Behavioral issues were observed as well. These
effects were not apparent in the groups exposed to the
smaller dosages.

Groups of rats were given the same treatment as
described previously but dispatched after 3 days. TUNELstained hippocampal neurons were compared between the
hippocampal sub-regions cornu ammonis 1 (CA1), CA2, and
CA3, and the dentate gyrus in rat pups. Groups subject to
lower doses of 25or 50 mg/kg did not have higher rates of
apoptosis while a group subjected to 75 mg/kg showed
significant apoptosis in these regions. Protein expression of
PKCγ, ERK1/2 and Bcl-2 in the hippocampus was measured
by western blot. The greater dose of ketamine inhibited pPKC, p-ERK1/2 and Bcl-2 manifestation but not that of tPKC or t-ERK. These findings corroborate the position that
the malign effects of ketamine are associated with p-PKC, p
-ERK1/2 and Bcl-2 expression, which in turn is related to
persistent destructive cognitive effects.

How long does a monkey need be exposed to
ketamine for neurodegeneration to occur? Although three
hours did not seem to cause neuoroapoptosis, exposure
for more than nine hours did, while exposure for twentyfour hours resulted in long term cognitive deficits (Figure
3). Most welcome is the knowledge that the 3 hour period
did not cause significant apoptosis, as this is the time
frame for an average surgery.
Figure 3. The effect of Ketamine over time. Note the insignificant effect over 3 hours. (Source: Zou et al. 2009)

Dikranian et al. (2001) suggested perhaps scientists were mistaken in comparing neuronal cells believed to
be undergoing apoptosis to non-neuronal cells. Maybe the
detailed biological structure of a neuronal cell undergoing
apoptosis would have a different ultrastructure than a corresponding cell in the rest of body. NMDA antagonists, and
GABAa agonists were used to effect neuroapoptosis and
the cellular ultrastructure of apoptotic cells was compared
to that of a physiologically dying cell as it occurs naturally
in the brain. It was verified to have similar properties to
that set forth by the Kerr/ Wyllie team, the scientists who
originally discovered and formulated the word apoptosis
and classified the structure and formation of such a cell.

Apoptosis Seen in Higher Primates
Perhaps only such an effect is observed in rats but
higher non-human primates such as the monkey would be
68
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Prolonged subjection to a high dosage of ketamine
in postnatal day 3 perinatal rhesus monkeys for 24 h, with
1, 10, or 20 µM of ketamine, an NMDA antagonist, caused
neurodegeneration in the frontal cortical area (Wang et al.
2006). Significant change in mitochondrial metabolism,
DNA factionalism, and the release of lactate dehydrogenase were also observed. These phenomena are all
characteristic of apoptosis.

issue applies to the human fetus and neonates? How can
such studies be done non-invasively in humans? While
studies can be done retrospectively on humans who have
already undergone treatment based on the incidence and
statistical distribution of apoptotic neurodegeneration,
there are many confounding factors such as the dosage
amount and duration, acid-base disturbances, hypoxia,
starvation, route of administration, developmental period,
and the subtype receptors activated. There are many cofactors present in humans absent in animals. To further
muddle the matter, pediatric patients typically are administered a combination of anesthetic agents such as benzodiazepines and/or anticholinergics, possibly reducing the
amount of ketamine needed to maintain a surgical plane.
Due to all these confounding factors, it is not clear if results from these studies can be extrapolated to humans.
Perhaps if the epidemiological studies were wellconstructed and accounted for various variables by setting
up groups of similar circumstances and arrange for a control for each group, it would aid in determining whether
the human brain is vulnerable to apoptotic devastation by
anesthetics. Or, methods can be developed for noninvasive
techniques to determine if in vivo neurodegeneration
takes place in the developing brain.

Even when ISO or ketamine was administered to 6
day old rhesus monkeys for just 5 hours to maintain a light
surgical plane and all physiological parameters were controlled as they would be for a neonate patient, neurodegeneration ensued (Brambrink et al. 2010). Pronounced
apoptotic neurodegeneration was especially apparent
among the immature oligodendrocyte glial cells participating in myelination as well as neurons. ISO, a widely used
anesthetic for maintaining a prolonged stable surgical
plane, was shown to cause approximately 4 times more
degeneration than ketamine.
Other studies discussed which regions of the brain
were affected but Creeley et al. (2013) pinpoints the specific cells - neurons and oligodendrocytes just beginning to
myellinate their axons - that were deleted. In this experiment, 120 day old fetuses of rhesus monkeys, (comparable
to a late third trimester human fetus) and 6 day old neonates (similar to the 4-6 month old human brain) were
subjected to propofol for 5 hours. A pronounced effect was
detected in the subcortical and caudal areas in the fetus.
The neonates caudal brain regions were affected less and
neurocortical regional damage formed distinct laminar
patterns.

Anesthetics - Similar to Ethanol?
Because of the similarities in the molecular pathways of intoxication and general anesthetic agents-ethanol
is both an NMDA antagonist and a GABA agonistIkonomidou et al. (2000) suspected that that studies on
the affects of ethanol on fetuses would be applicable to
general anesthetics. Seven day old rats were given 2.5 g/Kg
of 20% ethanol in saline, and compared to the control only
given saline. TUNEL and silver staining showed only modest
physiological cell death in the control while the subject
group showed condensed pervasive sections of degeneration. Creeley et al. (2013) presented the same affect on
neurons and oligondrocytes in the fetal macaque brain.

Sun et al. (2012) showed that even adolescent
monkeys, when administered ketamine regularly, developed permanent damage. This was evident from the apoptotic effectors present in the prefrontal cortex. Macaque
monkeys demonstrated abnormal behavior in their walk,
jump, climb, and general movements. The damage appeared permanent in the 6 month treated monkeys, while
Ethanol has a debilitating effect at the molecular
1 month treatment and control monkeys had no such dis- level. Above a 12 mol % (30.5 v/v %) threshold, desorption
play upon TUNEL testing.
results from breaks in the lipid-water interface of the bimembrane, some of the lipid fragments amalgamate withCan These Results be Extrapolated to Humans?
in the cell (Gurtovenko, Anwar, 2009). At the same time,
What can be done to determine definitively if this components of the inner and outer leaflets of the lipid bi69
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layer substitute one another’s position, permanently upsetting the membrane structure. And this suggests that
anesthetics may cause neurological damage just as ethanol
causes developmental neurological damage to fetuses
(fetal alcohol syndrome). Neurobehavioral deficiencies
perceived to persist into adulthood include psychosis, hyperactivity, learning disabilities, and depression.

But even if anesthetics are shown to definitively
cause neurodegeneration, clinical medicine is not much
further advanced. How can children who need surgery
safely receive treatment? Anesthetic application to children during surgery cannot simply be abandoned; its use
prevents neurotoxicity from developing in the brain as well
as the harmful effects of stress, anxiety and chronic pain
disorders. Exposure to prolonged or repeated painful stimuli lowers the threshold of pain processing, and alters development of the brain, cognitive functioning, and behavior. Moreover, surgical patients who were not administered anesthetics exhibited the very same pervasive neurodegeneration; nothing was gained by avoiding it. Anesthetic treatment resulted in attenuating the pain and protecting the developing brain. (Anand et al. 2004). Anesthetics also protect the brain from damage by preventing
hypoxic and ischemic incidents, allowing the necessary oxygen-carrying blood flow to continue to nurture the brain.

Anesthetics’ Affects Persist into Maturity
Wilder et al. (2009), in a population based cohort
study demonstrated retrospectively how children under 4
years of age subjected to an incidence of anesthesia were
unlikely to be affected. However, 2 or more periods of general anesthetic application revealed a cognitive deficit as
revealed by inferior scores on IQ and standardized achievement tests. Learning disabilities as characterized by poor
math, reading and writing skills were apparent and they
lagged continually further behind their peers as they advanced through school. By 19 years of age, 35% had a
learning disability, representing a 15% rise against the general population (Figure 4). Because of the controversy regarding how to relate the vulnerable developmental stage
of animals to their corresponding human stage, the experiment was repeated for children subjected to anesthesia for
two or more instances. Similar results were generated. It is
not clear if the anesthetics themselves or other factors
were the cause.

Apoptotic Mechanism

A possible mechanism for GA induced neuroapoptosis is via the mitochondrial pathway (Figure 5). Molecular
stimulation prompts association of Bcl-2 with mitochondrial Bcl-2, leading to the release of cytochrome c. Cytochrome c in turn binds Apaf-1, effecting a change in its
conformation. Apaf-1 association with procrease-9 allosterically activates it, in turn stimulating procaspase-3 and
procaspase-7. Perhaps a cascade induced by GAs cause the
mitochondria to release more cytochrome c, leading to
Figure 4: A population based cohort study demonstrating the
activation of more caspases. Sanchez et al. (2011) demonlong-term affect of multiple anesthetic incidence. (Source: Wilstrated support for the theory of GAs affecting mitochonder et al. 2009)
dria when he discovered that long term use of GAs compromised its structure and function as well as lingering dysfunction in inhibitory synapses in neural signaling.

Figure 5 : (Printed on next page) A schematic summary of the
apoptotic pathway. A stimulant triggers association of Bcl-2 with
mitochondrial Bcl-2. The ensuing series of reactions activates
caspases. (Source: Kalantri 2010)

Alternatively, Kuwana and Newmeyer (2003) suggests that GAs spur a release of a large concentration of Cl
(2+) from the ER lumen which can in turn lead to an increase in permeability of mitochondria. The mitochondria
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Genesis and Reversal of Apoptotic Nuerodegeneration in Developing Brain

swells and the external membrane may burst. The cytochrome c will then disperse throughout the cell and the
apoptotic cascade will begin. Bcl-2 can bring about apoptosis by controlling the release of Ca(2+), thereby regulating
whether mitochondria will burst and discharge cytochrome
c.

oxidation of fatty acids and is essential in skeletal muscle
metabolism. L-carnitine, when administered concurrent
with GAs, significantly minimized the damage even for long
periods under high dosages (Zou et al. 2008).
Di Marzio et al. (1997) reports that sphingolipids
play a key role in apoptosis; Apoptosis may be arrested by
inhibition of a sphingolipid activation cascade. L-carnitine
in AIDS patients blocked sphingomyelinase, thus preventing sphingomyelin breakdown into phosphocholine
and ceramide, an intracellular apoptotic effecting molecule. Ceramide exists in the mitochondrial pathway. When
high levels are present, the respiratory chain is prevented
and cytochrome c is released (Ghafourifar et al. 1999).
Mechanisms in neuropathic diseases also lead to
initiation of the apoptotic cascade with cytochrome c
released into the cytoplasm (Di Cesare Mannell et al.
2007). Treatment of rats with acetyl-L-carnitine reduced
the amount of cytochrome c present in the cytosol and
suppressed the apoptotic pathway. Unfortunately, Lcarnitine, when tested, did not provide successful
protection. Acetyl-L-carnitine also reduced the number of
chromatin undergoing the irreversible condensation of
chromatin characteristic of apoptotic cells (karyopyknosis).
While the exact apoptotic effecting pathway of
GAs is uncertain, it is probable that it is related to both
sphingomyelinase and the release of cytochrome c into the
cytoplasm. Consequently, it is likely that both L-carnitine
and acetyl-L-carnitine would aid in preventing apoptosis. It
is premature to declare whether one would be more successful than the other in preventing neuroapoptosis while
the basic pathways GAs trigger remain a mystery. Perhaps
L-carnitine and acetyl-L-carnitine’s shielding capacity is
applicable to only specific mechanisms initiated by a
specific anesthetic or a specific form of the anesthetic’s
administration.

Possible Protection Against Apoptosis
A viable alternative to GAs must be developed or
the underlying mechanisms better studied and understood
so as to address the specific toxic pathway. When ISO and
N2O were administered together, differential gene expression was observed in 45 pathways related to the brain,
highlighting the difficulties researchers have in trying to
pinpoint the exact pathway by which the apoptotic damage is caused and developing a drug to neutralize its
affects (Wang et al. 2012).

The X-chromosome linked inhibitor of apoptosis
protein (XIAP) acts as an important factor in the apoptotic
pathway, inhibiting apoptosis by blocking the activity of
caspase-3. When the GA sevuflorane was delivered to lung
carcinoma cells for up to 6 hours, apoptosis resulted,
blocking cell proliferation (Liang et al. 2011). Researchers
observed down-regulation of XIAP expression while caspa-

Once the exact apoptotic pathway is determined,
drugs can be developed to act in concert with the anesthetic to prevent the apoptotic cascade while maintaining
the benefits of a sedative effect. Progress in labs has already been made in identifying a possible “antidote,” Lcarnitine. L- carnitine is an amino protein that supports
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se-3 levels rose. But administration of Acetyl-L-carnitine
was shown to parallel a reduction of karyopyknosis,
suggesting the induction of XIAP to block this occurrence
(Di Cesare Mannell et al. 2007).

sante G, De Simone C, Cifone MG. 1997. Influence of L-carnitine on
CD95 cross-lining-induced apoptosis and ceramide generation in human
cell lines: correlation with its effects on purified acidic and neutral sphingomyelinases in vitro. Proceedings of the Association of American Physicians 109(2):154-63.

Conclusion

Ghafourifar P, Klein SD, Schucht O, Schenk U, Pruschy M, Rocha S, Richter C. 1999. Ceramide induces cytochrome c release from isolated mitochondria. Importance of mitochondrial redox state. The Journal of Biological Chemistry 274(10):6080-4.

While recent studies of rodents and primates
suggest that GAs may cause apoptosis in the developing
brain by its dual mechanism as an NMDA antagonist and
GABAa agonist, whether this applies to the developing
human brain remains inconclusive. Better constructed
epidemiological studies would probably be the best route
to determine unequivocally if the developing human brain
is vulnerable. Should it prove to be vulnerable, protection
in the form of L-carnitine and Acetyl-L-carnitine may be
used to neutralize the malevolent affects in future pediatric anesthesiology.
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